Bone Void Fillers Market Analysis

Bone Void Fillers Market Analysis

To get key market trends

  Download Free Sample

Based on material type, the market is divided into demineralized bone matrix, calcium sulfate, collagen matrix, tricalcium phosphate, and other material types. The demineralized bone matrix segment is estimated to account for USD 2.1 billion by 2032.
 

• Demineralized bone matrix (DBM) retains the natural bone structure providing an osteoconductive scaffold for new bone growth. It also contains growth factors that stimulate stem cells to differentiate into bone-forming cells (osteoinduction).
   
• According to the National Library of Medicine, in 2022, DBM was common in clinical use and accounted up to 50% of allografts used in the U.S. The collagen matrix and biologic components of DBM, particularly bone morphogenetic proteins (BMPs) are critical to its use as a bone graft and allow it to be used as a graft extender, thus leading to it greater adoption.
   
• DBM is used in various orthopedic procedures including spinal fusion, fracture repair, and joint reconstruction. It promotes the fusion of vertebrae and stabilizes the spine. Consequently, it is also used in revision surgeries where there is bone loss or non-union, providing a scaffold for bone growth.
   
• Further, the material undergoes processing to remove cellular components, reducing the risk of immune reactions or rejection.
   

Based on form, the bone void fillers market is segmented into gel, granules, paste, putty, and other forms. The putty segment accounted for USD 1 billion in 2023.
 

• Putty formulations have a moldable consistency allowing surgeons to easily shape and pack the material into bone defects and irregularities. It can conform to various bone contours and shapes, ensuring optimal contact with the bone surface for effective bone regeneration.
   
• These formulations contain demineralized bone matrix (DBM), growth factors, and other bone-promoting substances. Similarly, they are available in preserved and preservative-free forms, catering to different patient needs and preferences.
   
• For instance, according to the Leader Biomedical, in 2024, the synthetic putty can be used as bone void filler in spinal surgery, orthopedic braces and support, and orthopedic surgery and is a proven an excellent alternative to human bone especially when used in with bone marrow or proline-rich proteins (PRPs).
   
• Surgeons can precisely place putty in the desired location, ensuring targeted bone regeneration and minimizing material displacement. Thus, the continued innovation and development of putty formulations are expected to maintain the segment's dominance in the market.
   

Based on application, the bone void fillers market is segmented into spine fusion, bone fracture, joint reconstruction, and other applications. The bone fracture segment held a market share of 40.5% in the year 2023.
 

• Bone fractures are commonly caused by accidents, falls, sports injuries, and trauma. With the aging population there is an increased incidence of fractures due to osteoporosis and age-related bone weakness.
   
• Similarly, as per National Library of Medicine, each year an estimated 1.5 million individuals suffer a fracture due to bone disease. The risk of a fracture increases with age and is greatest in women. This increasing fracture rate accelerates the adoption of bone void fillers.
   
• Fractures of long bones such as the femur, tibia, and humerus require bone void fillers for repair. In complex fractures with bone loss or fragmentation these fillers are essential for reconstruction and are used to treat non-union fractures where bone healing has not occurred naturally.
   
• Surgeons use bone void fillers in combination with internal fixation devices such as bone plate, bone screw system, and nails to alleviate fractures.
   

Based on end-use, the bone void fillers market is classified into hospitals, orthopedic clinics, ambulatory surgical centers, and other end-users. The hospitals segment held a market size of USD 1.4 billion in 2023.
 

• Hospitals often have specialized orthopedic departments equipped to handle a wide range of bone-related conditions and surgeries. Surgeons in these departments are experienced in using bone void fillers and understand their role in enhancing surgical outcomes.
   
• These settings offer inpatient services for orthopedic surgeries where bone void fillers are commonly used. They provide postoperative care and monitoring, ensuring proper bone healing and integration of fillers.
   
• Further, increasing number of hospitals creates a greater demand for these fillers. For instance, according to Oxford Academy, in 2023, the number of hospitals in the U.S. dedicated to bone-related care is substantial, with a total of 6,120 hospitals in the country. These hospitals play a crucial role in providing specialized care for bone fractures, osteoporosis, and other orthopedic conditions.
   
• Hospitals purchase bone void fillers in bulk taking advantage of economies of scale and negotiating lower prices. Bulk purchasing allows hospitals to reduce costs per unit making bone void fillers a cost-effective solution, thereby strengthening the growth of the market.
   

North America bone void fillers market accounted for USD 1.4 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The aging population in the region leads to an increased prevalence of orthopedic conditions such as fractures, osteoporosis, and degenerative bone diseases. For instance, according to the Population Reference Bureau, the number of Americans aged 65 and older was 58 million in 2022 and is projected to reach 82 million by 2050.
   
• North America is a hub for medical device innovation with the development of advanced bone void fillers using cutting-edge technologies. Surgeons in the region often employ minimally invasive techniques where bone void fillers play a crucial role in enhancing outcomes.
   
• Robust healthcare reimbursement systems in the U.S. and Canada provide coverage for bone void fillers, making them more accessible to patients and healthcare facilities. For instance, Medicare in the U.S. covers bone void fillers for eligible patients, encouraging their use in orthopedic surgeries.
   
• The presence of multiple key players fosters competition, leading to product innovations and advancements in bone void fillers. Companies frequently launch new and improved bone void fillers, expanding the market and addressing specific surgical needs, thereby stimulating the growth of the market.